email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2644-1306

Theranostics of Respiratory & Skin Diseases

Research Article(ISSN: 2644-1306)

Oculcutaneous Disease, Rosacea: Review Article

Volume 1 - Issue 2

Amal O Al-Balbeesi*

  • Author Information Open or Close
    • Assistant Professor, Department of Dermatology, King Khalid University Hospital, King Saud University, Saudi Arabia

    *Corresponding author: Amal O Al-Balbeesi, Assistant Professor, Department of Dermatology, King Khalid University Hospital, King Saud University, Saudi Arabia

Received: July 04, 2018;   Published: July 17, 2018

DOI: 10.32474/TRSD.2018.01.000107

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Ocular manifestations of rosacea are commonly nonspecific and variable. The etiology of the inflammation is not fully known and there is no definite diagnostic test for the disease. We often under diagnose the disease, despite the potential for serious sightthreatening sequelae. When evaluating patients with rosacea, dermatologists and family physicians should obtain a careful history of eye complaints and examine the eyelid margins thoroughly. Patients with moderate-to-severe ocular findings will benefit from evaluation by an ophthalmologist. Controlling symptoms and preventing potential risk of blindness should be the aim of early diagnosis and prompt intervention. The mainstay of treatment is good lid hygiene, topical metronidazole, topical azithromycin eye drops, topical cyclosporine, and oral tetracycline.

The aim of this review is to shed light on the signs of ocular rosacea, dermatologists and family physicians must be familiar with, the understanding of the pathogenesis of this old disease of skin and the eye since the original observation by Von Arlt in 1864 and its treatment.

Quality of Evidence

A Pubmed search of English-language literature from August 1931 to April 2018 revealed a combination of prospective cohort studies and descriptive studies, with a predominance of descriptive studies based on clinical experience. The MeSH terms; eye, skin, rosacea was used, as well as the non-MeSH terms ocular and oculocutaneous. The articles selected for assessment were the ones that provided complete clinical reviews of relevance, i.e., they provided a thorough review of the clini¬cal presentation of ocular rosacea, its pathophysiology, diagnosis and treatment options.

Abstract| Introduction| Pathophysiology: Figure 1| Therapy| Conclusion| Acknowledgment| References|

https://www.high-endrolex.com/21